Outlook Therapeutics, Inc.
OTLK • NASDAQ
Outlook Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert Charles Jahr, with a market cap of $23.2M.
Market Cap$23.2M
Employees24.0
CEORobert Charles Jahr
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ2 2026
Financials
Outlook Therapeutics, Inc. FAQ
Common questions about Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. is scheduled to report earnings for Q2 2026 on May 14, 2026. Analysts estimate revenue of $4.4M.
Outlook Therapeutics, Inc. has approximately 24 employees.